Aziyo Biologics to Report First Quarter 2021 Financial Results on Tuesday, May 4, 2021

Rhea-AI Summary

Aziyo Biologics (Nasdaq: AZYO) announced plans to release its first quarter earnings results on May 4, 2021, after market close. The management will host a conference call at 4:30 PM ET to discuss financial performance, which will also be available via webcast. Aziyo focuses on developing products aimed at improving surgical outcomes, particularly for patients with implantable medical devices. The company has a portfolio in cardiovascular, orthopedic, and reconstructive specialties, highlighting its growth in the regenerative medicine sector.

Positive

• Focus on regenerative medicine with a portfolio in cardiovascular and orthopedic specialties.
• Scheduled earnings release and conference call indicate transparency and investor engagement.

Negative

• None.

SILVER SPRING, Md., April 20, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced that it plans to release its first quarter earnings results after market close on Tuesday, May 4, 2021. Management will host a conference call to review the company’s financial performance starting at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on the same day. The conference call will be concurrently webcast.

The link to the webcast will be available on the Aziyo website at www.aziyo.com under the investor relations section and will be archived for future reference. To listen to the conference call, please dial (800) 708-4539 (US/Canada) or (847) 619-6396 (International) and use the conference ID number 50150586 approximately ten minutes prior to the start time.

About Aziyo Biologics
Aziyo Biologics is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. Since its founding in 2015, the Company has created a portfolio of commercial-stage products used in cardiovascular, orthopedic, and reconstructive specialties. For more information, visit www.Aziyo.com.        

Investors:
Leigh Salvo
Gilmartin Group
investors@aziyo.com

Media:
Courtney Guyer
Aziyo Biologics, Inc.
PR@aziyo.com

FAQ

When will Aziyo Biologics release its Q1 earnings results?

Aziyo Biologics will release its Q1 earnings results on May 4, 2021, after market close.

What time is the Aziyo Biologics conference call?

The conference call will begin at 4:30 PM Eastern Time on May 4, 2021.

How can I access the Aziyo Biologics earnings conference call?

The conference call can be accessed by dialing (800) 708-4539 for US/Canada participants or (847) 619-6396 for international participants, using conference ID 50150586.

What is the focus of Aziyo Biologics?

Aziyo Biologics is focused on creating differentiated regenerative medicine products to improve outcomes for patients undergoing surgery.